Osteoprotegerin: A valid new marker of bone turnover in post-menopausal osteoporosis?

Journal of Orthopaedics and Traumatology

Volumn 6, Issue 2, 2005, Pages 88-90

  Ulivieri, F M ^a   Piodi, L P ^a   Marchelli, D ^a   Corradini, C ^b   Verdoia, C ^b   Gerundini Gherardi, P ^a  

^a IRCCS   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Bone mineral density; Bone turnover markers; Osteoprotegerin; Post menopausal osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE BONE ISOENZYME; BIOLOGICAL MARKER; DEOXYPYRIDINOLINE; OSTEOCALCIN; OSTEOPROTEGERIN;

ADULT; AGE; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; BONE MASS; BONE TURNOVER; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; FEMUR; HUMAN; LUMBAR SPINE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; STUDENT T TEST;

EID: 22844442670     PISSN: 15909921     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10195-005-0087-4     Document Type: Article

References (5)

1. Aubin JE, Bonnelye E (2000) Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption. Osteoporos Int 11:905-913
2. Yano K, Tsuda E, Washida N, Kobayashi F, Goto M, Harada A, Ikeda K, Higashio K, Yamada Y (1999) Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis. J Bone Miner Res 14(4):518-527
3. Hofbauer LC, Schoppet M (2001) Serum measurement of osteoprotegerin - clinical relevance and potential applications. Eur J Endocrinol 145:681-683
4. Rogers A, Saleh G, Hannon RA, Greenfield D, Eastell R (2002) Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women. J Clin Endocrinol Metab 87(10):4470-4475
5. Ueland T, Brixen K, Mosekilde L, Mosekilde L, Flyvbjerg A, Bollerslev J (2003) Age-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: A cross-sectional study. J Clin Endocrinol Metab 88(3):1014-1018